PharmacyCodes



Dergotamine en es it fr

Dergotamine Brand names, Dergotamine Analogs

Dergotamine Brand Names Mixture

  • No information avaliable

Dergotamine Chemical_Formula

C33H37N5O5

Dergotamine RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Dergotamine fda sheet

Dergotamine FDA

Dergotamine msds (material safety sheet)

Dergotamine MSDS

Dergotamine Synthesis Reference

No information avaliable

Dergotamine Molecular Weight

583.678 g/mol

Dergotamine Melting Point

No information avaliable

Dergotamine H2O Solubility

No information avaliable

Dergotamine State

Solid

Dergotamine LogP

No information avaliable

Dergotamine Dosage Forms

Liquid

Dergotamine Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Dergotamine Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Dergotamine Absorption

Interpatient variable and may be dependent on the administration technique

Dergotamine side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Dergotamine Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Dergotamine Organisms Affected

Humans and other mammals